Atypical features of MDD
Reading File
Finding Sources
Searching PubMed
"atypical depression" AND specifier AND features
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive information from the textbooks. Here is a full, well-organized answer:
Atypical Features of Major Depressive Disorder (DSM-5 Specifier)
"With atypical features" is a specifier that can be applied to a current major depressive episode in MDD, bipolar I, bipolar II, or persistent depressive disorder (dysthymia). The term is somewhat misleading - this presentation is actually quite common.
DSM-5 Criteria
To qualify, the episode must meet Criterion A (mood reactivity) plus at least 2 of the 4 associated features (Criteria B):
Criterion A - Essential Feature (Must be Present)
Mood Reactivity
- The patient's mood brightens in response to actual or potential positive events
- This is the hallmark feature that distinguishes atypical from other MDD subtypes
- The patient can feel genuinely better (not just transiently) when something good happens
- Contrast with melancholic depression, where mood is non-reactive ("pervasive anhedonia")
Criterion B - Associated Features (2+ Required)
| Feature | Description |
|---|---|
| Hyperphagia / Weight gain | Increased appetite or significant weight gain (reversed vegetative sign vs. the typical anorexia/weight loss) |
| Hypersomnia | Sleeping too much (10+ hours/day), excessive daytime sleepiness; sleep disturbed in the first half of the night is common |
| Leaden paralysis | Heavy, leaden feeling in the arms or legs; not the same as fatigue - described as a physical sensation of heaviness lasting at least 1 hour/day |
| Rejection sensitivity | Longstanding pattern of heightened sensitivity to interpersonal rejection or criticism, causing significant social/occupational impairment; not limited to the episode itself - it is a persistent trait |
Additional Exclusion Criterion
Melancholic features or catatonia must not be present during the same episode (these take precedence and override the atypical specifier).
Key Clinical Features and Associations
Reverse vegetative signs - the core pattern:
- Hypersomnia (vs. insomnia)
- Hyperphagia/weight gain (vs. anorexia/weight loss)
- Mood worse in the evening (vs. diurnal variation with morning worsening seen in melancholia)
- Some authors include increased sexual interest as an additional reverse vegetative sign
Relationship to bipolar spectrum:
- Atypical depression has considerable affinity with bipolar II and III disorders
- Many patients with dysthymia exhibit atypical features periodically
- A subset of atypical depression patients meet criteria for brief hypomania or cyclothymia
- Atypical depression overlaps conceptually with hysteroid dysphoria (a precursor construct)
Temperament: Patients tend to have sensitive, reactive temperamental traits and often have comorbid anxiety, phobias, and somatic symptoms - Kaplan & Sadock's Comprehensive Textbook of Psychiatry, p. 5066
Contrast: Atypical vs. Melancholic Features
| Feature | Atypical | Melancholic |
|---|---|---|
| Mood reactivity | Present (brightens with good news) | Absent (persistently unresponsive) |
| Sleep | Hypersomnia | Early morning awakening |
| Appetite/weight | Hyperphagia, weight gain | Anorexia, weight loss |
| Diurnal variation | Worse in evening | Worse in morning |
| Psychomotor | May be retarded | Agitation or retardation |
| Guilt | Less prominent | Prominent, often excessive |
Treatment Implications
- MAOIs (especially phenelzine) were historically first-line for atypical depression, outperforming TCAs significantly (72% vs. 44% response in the Columbia trials)
- SSRIs and bupropion are effective and commonly used (a head-to-head trial showed phenelzine 85% vs. fluoxetine 80% - no significant difference)
- CBT has equivalent efficacy to phenelzine (58% vs. 58% in controlled trials)
- TCAs are less effective than MAOIs in atypical depression - this pharmacological distinction originally helped define the subtype
- Maintenance with an effective agent is important: switching from phenelzine to placebo led to 87% recurrence rates - Kaplan & Sadock's Comprehensive Textbook of Psychiatry, p. 9647
Memory Aid
"MARSH" for the associated features:
- Mood reactivity (essential)
- Appetite increased / weight gain
- Rejection sensitivity
- Sleep (hypersomnia)
- Heavy limbs (leaden paralysis)
This is a shared conversation. Sign in to Orris to start your own chat.